review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.3389/FIMMU.2016.00451 |
P8608 | Fatcat ID | release_gbg23clevffltj5spso5vfmvte |
P3181 | OpenCitations bibliographic resource ID | 2806431 |
P932 | PMC publication ID | 5078318 |
P698 | PubMed publication ID | 27826298 |
P2093 | author name string | Meike Mitsdoerffer | |
Anneli Peters | |||
P2860 | cites work | IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production | Q24338636 |
Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 | Q24648620 | ||
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis | Q26771459 | ||
The Ins and Outs of B Cells in Multiple Sclerosis | Q26776542 | ||
Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues | Q26778348 | ||
A role for Th17 cells in the regulation of tertiary lymphoid follicles | Q26851559 | ||
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules | Q27308814 | ||
Structural and functional features of central nervous system lymphatic vessels | Q27316769 | ||
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
Revisiting the Mechanisms of CNS Immune Privilege | Q30278584 | ||
Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors | Q30279169 | ||
Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis | Q30510541 | ||
2-photon imaging of phagocyte-mediated T cell activation in the CNS. | Q30536629 | ||
Revised diagnostic criteria of multiple sclerosis | Q30733519 | ||
Gray matter damage in multiple sclerosis: Impact on clinical symptoms | Q30979785 | ||
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice | Q33399367 | ||
Cortical lesions in multiple sclerosis | Q33631075 | ||
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis | Q33862720 | ||
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. | Q34052870 | ||
Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes | Q34066077 | ||
Proinflammatory T helper type 17 cells are effective B-cell helpers | Q34069686 | ||
B cells regulate autoimmunity by provision of IL-10. | Q34150590 | ||
The development of inducible bronchus-associated lymphoid tissue depends on IL-17. | Q34191942 | ||
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. | Q34251673 | ||
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis | Q34295012 | ||
Real-time in vivo analysis of T cell activation in the central nervous system using a genetically encoded calcium indicator | Q34345420 | ||
Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space | Q34449329 | ||
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis | Q34538912 | ||
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin | Q34960518 | ||
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. | Q35009513 | ||
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice | Q35009518 | ||
Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation | Q35084618 | ||
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes | Q35298764 | ||
Inflammatory cortical demyelination in early multiple sclerosis | Q35764685 | ||
IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs | Q36055624 | ||
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis | Q36065424 | ||
RORγt Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis | Q36076923 | ||
Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune Disease | Q36097332 | ||
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation | Q36161486 | ||
Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation | Q36174679 | ||
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation. | Q49130159 | ||
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis | Q53438445 | ||
Lineage Relationship Analysis of RORγt+Innate Lymphoid Cells | Q57520258 | ||
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions | Q59070288 | ||
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid | Q59543689 | ||
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions | Q60197446 | ||
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein | Q60455093 | ||
Immunopathology of multiple sclerosis | Q63285399 | ||
Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis | Q63535318 | ||
B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide | Q73170385 | ||
Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein | Q74456215 | ||
The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions | Q81485093 | ||
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain | Q36229219 | ||
Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma | Q36361169 | ||
Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease | Q36380402 | ||
Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein | Q36380584 | ||
Lymphoid organ development: from ontogeny to neogenesis | Q36426808 | ||
Germinal-center organization and cellular dynamics | Q36459345 | ||
Mechanisms regulating regional localization of inflammation during CNS autoimmunity. | Q36918129 | ||
Follicular dendritic cells emerge from ubiquitous perivascular precursors | Q36991851 | ||
Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis | Q37354974 | ||
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions | Q37646434 | ||
Stromal cell-immune cell interactions | Q37809072 | ||
Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes | Q37925555 | ||
The clinical course of multiple sclerosis | Q38186214 | ||
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. | Q38196701 | ||
Th17 cells in central nervous system autoimmunity | Q38200386 | ||
Ectopic lymphoid-like structures in infection, cancer and autoimmunity | Q38221815 | ||
The biology of innate lymphoid cells | Q38319907 | ||
Role of the innate and adaptive immune responses in the course of multiple sclerosis | Q38384621 | ||
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients. | Q38526863 | ||
IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs | Q38641655 | ||
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis | Q38954794 | ||
Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis | Q41184150 | ||
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord | Q41466361 | ||
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis | Q42463447 | ||
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. | Q42847184 | ||
Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response | Q43887998 | ||
Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice | Q44484576 | ||
Identification of autoantibodies associated with myelin damage in multiple sclerosis | Q46424597 | ||
IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium | Q46485022 | ||
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration | Q47680006 | ||
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis | Q48315824 | ||
CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis | Q48365016 | ||
Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis | Q48485900 | ||
Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination | Q48489118 | ||
Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephal | Q48494770 | ||
A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination | Q48530177 | ||
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis | Q48932530 | ||
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis | Q48949792 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | tertiary lymphoid organ | Q108017266 |
P304 | page(s) | 451 | |
P577 | publication date | 2016-10-25 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Tertiary Lymphoid Organs in Central Nervous System Autoimmunity | |
P478 | volume | 7 |
Q92538007 | Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation |
Q64996917 | Contribution of LTi and TH17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis. |
Q57175799 | Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line |
Q63363253 | Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE |
Q89495110 | Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells |
Q49795149 | Lymphotoxin β receptor-mediated NFκB signaling promotes glial lineage differentiation and inhibits neuronal lineage differentiation in mouse brain neural stem/progenitor cells |
Q64118459 | Mechanisms of neurobehavioral abnormalities in multiple sclerosis: Contributions from neural and immune components |
Q57825775 | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis |
Q89278062 | Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer |
Q41000187 | Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease. |
Q64242492 | Severe headache in primary Sjögren's syndrome treated with intrathecal rituximab |
Q39110320 | T cell responses in the central nervous system |
Q90578057 | T lymphocytes and cytotoxic astrocyte blebs correlate across autism brains |
Q58746430 | Tertiary Lymphoid Structures: Autoimmunity Goes Local |
Q39201665 | Tertiary lymphoid organs in systemic autoimmune diseases: pathogenic or protective? |
Q41848000 | Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models. |
Search more.